Interventional Neurology Devices Market: By Product Type (Cerebral Balloon Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Aneurysm Coiling and Embolization Devices), By Technology Type (Carotid artery angioplasty and stenting, Vertebroplasty, Stroke therapy, Pre-operative tumour embolization), By Indication (Cerebral aneurysm, Ischemic strokes, Arteriovenous malformations and Fistulas, Others), By End User (Hospitals, Neurology Clinics, Ambulatory surgical centres) and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Interventional Neurology Devices Market size valued USD 2.5 billion in 2022 and is poised to grow at a CAGR of 9.2% from 2023-2029. Interventional neurology is a speciality which utilizes the minimally invasive procedures with image-guided techniques for the diagnosis and treatment of various chronic neurological diseases related to veins & arteries of neck, brain, and spine. The most commonly treated diseases with interventional neurology include head and neck tumours, ischemic strokes, meningiomas, spinal vascular malformations, cerebral aneurysm, and intracranial atherosclerosis among others. Different types of materials such as cobalt, platinum, and nitinol are used in neurovascular devices for ischemic stroke prevention and aneurysm. Increase in the global aging population, technological advancements in the interventional neurology devices, a rise in prevalence of ischemic stroke and hemorrhagic conditions, and growing demand for minimally invasive procedures are anticipated to fuel the interventional neurology devices market. Furthermore, advantages of an interventional procedure such as the minimal possibility of infection and surgical trauma, favourable reimbursement policies, and rise in product development and commercialization are expected to bolster the interventional neurology devices market over the forecast period. However, stringent regulatory guidelines for the product approvals, a high cost of the treatment, and lack of skilled professionals might impede the growth of  the market.

Interventional Neurology Devices Market Key Developments:
  • In June 2017, DePuy Synthes acquired Sentio, LLC to enable the innovation in minimally invasive surgery of spine In October 2016, St. Jude Medical, Inc. received FDA approval for Amplatzer PFO used in the treatment of recurrent ischemic stroke and launched in U.S. market

Global Interventional Neurology Devices Market Summary

Study Period

2023-29

Base Year

2022

CAGR

9.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Interventional Neurology Devices Market Dynamics

Interventional Neurology Devices Market is growing at a significant CAGR owing to increase in the demand for minimally invasive neurological surgical procedures. A rise in the prevalence of neurological disorders (according to World Health Organization, more than 6.8 Mn people are dying from neurological disorders) expected to drive the revenue growth of interventional neurology devices market. Moreover, a majority of the market players are focusing on the development of novel devices with minimally invasive techniques. Acquisitions and mergers, collaborations, product approvals, and launchings are strategies followed by the companies for dominating the interventional neurology devices market. For instance, in June 2016, Terumo Corporation acquired Sequent Medical, Inc. for the development of a novel medical device for the aneurysm embolization. Moreover, in January 2012, Covidien received FDA approval for the Solitaire revascularization device interventional management of stroke trial.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Interventional Neurology Devices Market Segmentation

By Product Type
  • Carotid artery angioplasty and stenting
  • Vertebroplasty
  • Stroke therapy
  • Pre-operative tumour embolization
By Indication
  • Cerebral aneurysm
  • Ischemic strokes
  • Arteriovenous malformations and Fistulas
  • Others
By End User
  • Hospitals
  • Neurology Clinics
  • Ambulatory surgical centres
By Technology Type
  • Carotid artery angioplasty and stenting,
  • Vertebroplasty,
  • Stroke therapy,
  • Pre-operative tumour embolization

Frequently Asked Questions

The key segments covered in the interventional neurology devices market are: by product type, technology type, indication, end-users and geography

The interventional neurology devices market key players are Medtronic plc) (Ireland), Stryker Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.)

North America is the fastest-growing region for interventional neurology devices market

1. Executive Summary
2. Global Interventional Neurology Devices Market Introduction 
2.1.Global Interventional Neurology Devices Market  - Taxonomy
2.2.Global Interventional Neurology Devices Market  - Definitions
2.2.1.Product Type
2.2.2.Indication
2.2.3.End User
2.2.4.Technology Type
2.2.5.Region
3. Global Interventional Neurology Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Interventional Neurology Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Interventional Neurology Devices Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Carotid artery angioplasty and stenting
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Vertebroplasty
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Stroke therapy
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Pre-operative tumour embolization
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Interventional Neurology Devices Market  By Indication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cerebral aneurysm
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ischemic strokes
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Arteriovenous malformations and Fistulas
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Interventional Neurology Devices Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Neurology Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory surgical centres
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Interventional Neurology Devices Market  By Technology Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Carotid artery angioplasty and stenting,
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Vertebroplasty,
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Stroke therapy,
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Pre-operative tumour embolization
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Interventional Neurology Devices Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Carotid artery angioplasty and stenting
10.1.2.Vertebroplasty
10.1.3.Stroke therapy
10.1.4.Pre-operative tumour embolization
10.2.  Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cerebral aneurysm
10.2.2.Ischemic strokes
10.2.3.Arteriovenous malformations and Fistulas
10.2.4.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Neurology Clinics
10.3.3.Ambulatory surgical centres
10.4.  Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Carotid artery angioplasty and stenting,
10.4.2.Vertebroplasty,
10.4.3.Stroke therapy,
10.4.4.Pre-operative tumour embolization
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Carotid artery angioplasty and stenting
11.1.2.Vertebroplasty
11.1.3.Stroke therapy
11.1.4.Pre-operative tumour embolization
11.2.  Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cerebral aneurysm
11.2.2.Ischemic strokes
11.2.3.Arteriovenous malformations and Fistulas
11.2.4.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Neurology Clinics
11.3.3.Ambulatory surgical centres
11.4.  Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Carotid artery angioplasty and stenting,
11.4.2.Vertebroplasty,
11.4.3.Stroke therapy,
11.4.4.Pre-operative tumour embolization
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12. Asia Pacific (APAC) Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Carotid artery angioplasty and stenting
12.1.2.Vertebroplasty
12.1.3.Stroke therapy
12.1.4.Pre-operative tumour embolization
12.2.  Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cerebral aneurysm
12.2.2.Ischemic strokes
12.2.3.Arteriovenous malformations and Fistulas
12.2.4.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Neurology Clinics
12.3.3.Ambulatory surgical centres
12.4.  Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Carotid artery angioplasty and stenting,
12.4.2.Vertebroplasty,
12.4.3.Stroke therapy,
12.4.4.Pre-operative tumour embolization
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Carotid artery angioplasty and stenting
13.1.2.Vertebroplasty
13.1.3.Stroke therapy
13.1.4.Pre-operative tumour embolization
13.2.  Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cerebral aneurysm
13.2.2.Ischemic strokes
13.2.3.Arteriovenous malformations and Fistulas
13.2.4.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Neurology Clinics
13.3.3.Ambulatory surgical centres
13.4.  Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Carotid artery angioplasty and stenting,
13.4.2.Vertebroplasty,
13.4.3.Stroke therapy,
13.4.4.Pre-operative tumour embolization
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Carotid artery angioplasty and stenting
14.1.2.Vertebroplasty
14.1.3.Stroke therapy
14.1.4.Pre-operative tumour embolization
14.2.  Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cerebral aneurysm
14.2.2.Ischemic strokes
14.2.3.Arteriovenous malformations and Fistulas
14.2.4.Others
14.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospitals
14.3.2.Neurology Clinics
14.3.3.Ambulatory surgical centres
14.4.  Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Carotid artery angioplasty and stenting,
14.4.2.Vertebroplasty,
14.4.3.Stroke therapy,
14.4.4.Pre-operative tumour embolization
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Medtronic plc) (Ireland)
15.2.2.Stryker Corporation (U.S.)
15.2.3.Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.)
15.2.4.Abbott Laboratories (U.S.)
15.2.5.Terumo Corporation (Japan)
15.2.6.Bayer AG (Germany)
15.2.7.Boston Scientific Corporation (U.S.)
15.2.8.Penumbra, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Medtronic plc) (Ireland)
  • Stryker Corporation (U.S.)
  • Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.)
  • Abbott Laboratories (U.S.)
  • Terumo Corporation (Japan)
  • Bayer AG (Germany)
  • Boston Scientific Corporation (U.S.)
  • Penumbra, Inc. (U.S.)